Archives of Clinical Infectious Diseases

Published by: Kowsar

Seroepidemiology of Bordetella pertussis Infection in Fresh College Students in Iran: A Multicenter Study

Iraj Sedighi 1 , Hamid Rahimi 2 , Monir Sadat Emadoleslami 3 , Alireza Fahimzad 4 , Firuzeh Hosseini 1 , Mandana Afsharian 5 , Ahmad Akbarzadeh 6 , Homayon Vahedi 3 , Ali Amanati 4 , Mansour Rezaei 5 and Keyghobad Ghadiri. 5 , *
Authors Information
1 Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Infectious Diseases, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, IR Iran
4 Department of Pediatrics, Pediatric Infectious Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Department of Pediatrics, Nosocomial Infections Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
6 Department of Pediatrics, Semnan University of Medical Siences, Semnan, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 30, 2014, 9 (1); e17922
  • Published Online: January 25, 2014
  • Article Type: Research Article
  • Received: January 1, 2014
  • Accepted: January 10, 2014
  • DOI: 10.5812/archcid.17922

To Cite: Sedighi I, Rahimi H, Emadoleslami M S, Fahimzad A, Hosseini F, et al. Seroepidemiology of Bordetella pertussis Infection in Fresh College Students in Iran: A Multicenter Study, Arch Clin Infect Dis. 2014 ; 9(1):e17922. doi: 10.5812/archcid.17922.

Abstract
Copyright © 2014, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. James D, Cherry UH. Pertusssis and other Bordetella infections. 2009; 1
  • 2. Sarah SL, Behrman K, Jenson S. Nelson textbook of pediatrics. 2007;
  • 3. James D. Cherry, Emmanuel Grimprel, Nicole Guiso, Ulrich Heiningerand Jussi Mertsola, Defining Pertussis Epidemiology, Microbiologic and Serologic Perspectives. Pediatr Infect Dis J. 2005; 24(5): 25-35
  • 4. de Juanes JR, Gil A, Gonzalez A, Arrazola MP, San-Martin M, Esteban J. Seroprevalence of pertussis antibody among health care personnel in Spain. Eur J Epidemiol. 2004; 19(1): 69-72[PubMed]
  • 5. Jackson LA, Cherry JD, Wang SP, Grayston JT. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis. 2000; 31(1): 3-6[DOI][PubMed]
  • 6. Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005; 24(8): 721-8[PubMed]
  • 7. Aaron M, Wendelboe JG, Michael G, Emmanuel G, David G, Scott H, et al. Transmission of Bordetella pertussis to Young Infants. Pediatr Infect Dis J. 2005; 24(6): 510-3
  • 8. Chris A, Morgan M, James D, Cherry PC, Karen L, Evelyn P, et al. Blumberg.A Search for Bordetella pertussis Infection in University Students. Clinic Infect Dis. 1992; 14(4): 64-71
  • 9. Zepp F, Knuf M, Habermehl P, Schmitt JH, Rebsch C, Schmidtke P, et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun. 1996; 64(10): 4078-84[PubMed]
  • 10. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005; 24(6 Suppl)-8[PubMed]
  • 11. Aaron M, Annelies VR, Stefania S. Duration of Immunity Against Pertussis After Natural Infection or Vaccination. Pediatr Infect Dis J. 2005; 24(5): 58-61
  • 12. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984; 14(2): 1-78[PubMed]
  • 13. Chiu TF, Lee CY, Lee PI, Lu CY, Lin HC, Huang LM. Pertussis seroepidemiology in Taipei. J Formos Med Assoc. 2000; 99(3): 224-8[PubMed]
  • 14. Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol. 2004; 11(6): 1045-53[DOI][PubMed]
  • 15. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005; 24(5 Suppl)-34[PubMed]
  • 16. Guinto-Ocampo H, Bennett JE, Attia MW. Predicting pertussis in infants. Pediatr Emerg Care. 2008; 24(1): 16-20[DOI][PubMed]
  • 17. Elliott E, McIntyre P, Ridley G, Morris A, Massie J, McEniery J, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J. 2004; 23(3): 246-52[PubMed]
  • 18. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004; 23(11): 985-9[PubMed]
  • 19. Jeffrey P. Davis, Chief Medical Officer and State Epidemiologist For Communicable Disease. . CDC Pertussis Treatment Guidelines. 2005;
  • 20. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006; 117(3): 965-78[DOI][PubMed]
  • 21. Lopez AL, Pineda E, Garakian A, Cherry JD. Effect of heat inactivation of serum on Bordetella pertussis antibody determination by enzyme-linked immunosorbent assay. Diagn Microbiol Infect Dis. 1998; 30(1): 21-4[PubMed]
  • 22. Trudy M, Kris B, DVM , Gary S. Duration of Immunity Against Pertussis After Natural Infection or vaccination. Pediatr Infect Dis J. 2005; 24(5): 58-61
  • 23. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006; 53(2): 106-13[DOI][PubMed]
  • 24. Wilder-Smith A, Ng S, Earnest A. Seroepidemiology of pertussis in the adult population of Singapore. Ann Acad Med Singapore. 2006; 35(11): 780-2[PubMed]
  • 25. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med. 1996; 334(6): 341-8[DOI][PubMed]
  • 26. Inandi T, Guraksin A, Hacialioglu N. Seroprevalence of pertussis among children in Eastern Turkey. Public Health. 2005; 119(6): 550-5[DOI][PubMed]
  • 27. Stroffolini T, Giammanco A, Chiarini A, Taormina S, Sarzana A, Mazza G, et al. Seroepidemiology of pertussis infection in an urban childhood population in Cameroon. Eur J Epidemiol. 1991; 7(1): 64-7[PubMed]
  • 28. Izadi M, Afsharpaiman S, Jonaidi Jafari N, Ranjbar R, Gooya MM, Robat Sarpooshi J, et al. Immunization status of Iranian military recruits against Bordetella pertussis infection (whooping cough). J Infect Dev Ctries. 2011; 5(3): 224-6[PubMed]
  • 29. Hashemi SH, Ranjbar M, Hajilooi M, Seif-Rabiei MA, Bolandi M, Moghimi J. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis. 2009; 9: 58[DOI][PubMed]
  • 30. Long SS. In Nelson textbook of Pediatrics. 2011;
  • 31. Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics. 2000; 105(1)[PubMed]
  • 32. Report of the America Academy of Pediatrics Commitee on Infectious Diseases 2009;
  • 33. ACIP expands Tdap recommendations. An update from the Michigan Department of Community Health. Mich Med. 2011; 110(2): 22-3[PubMed]
  • 34. LoMurray K, Sander M. Using the North Dakota Immunization Information System to determine adolescent vaccination rates and uptake. Public Health Rep. 2011; 126 Suppl 2: 78-86[PubMed]
  • 35. Lindley MC, Smith PJ, Rodewald LE. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Rep. 2011; 126 Suppl 2: 124-34[PubMed]
  • 36. Grenfell B. Boosting understanding of pertussis outbreaks. Proc Natl Acad Sci U S A. 2011; 108(18): 7279-80[DOI][PubMed]
  • 37. Chadambuka A, Chimusoro A, Apollo T, Tshimanga M, Namusisi O, Luman ET. The need for innovative strategies to improve immunisation services in rural Zimbabwe. Disasters. 2012; 36(1): 161-73[DOI][PubMed]
  • 38. Lutynska A, Wiatrzyk A, Mosiej E, Zawadka M. [Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis]. Przegl Epidemiol. 2011; 65(1): 45-50[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments